Marksans Pharma shareholding pattern
MARKSANS
168.06
7.00 (4.35%)Last updated on 1 Feb, 2026 | 15:52 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Marksans Pharma reports the following shareholding: Total Promoters at 43.87%, Mutual Fund at 4.41%, Insurance at 0%, Foreign Institutional Investors at 8.13%, Domestic Institutional Investors at 1.49%, and Retail at 42.09%. This breakdown provides a quick snapshot of ownership distribution for Marksans Pharma in 2025-26.
Marksans Pharma FAQs
As of 02-2026, the promoter shareholding in Marksans Pharma stands at 43.87% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Marksans Pharma is 8.13% and 1.49% respectively.
The retail shareholding of the Marksans Pharma is 42.09%.
Changes in shareholding patterns of Marksans Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Marksans Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
